| |
|
|
| Name: |
Cormorant Asset Management LLC |
| City: |
BOSTON |
| State: |
MA |
| Zip: |
02110 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
65 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MLTX |
Multisys Language Solutions... |
1 |
- |
$0.00 |
$426,661,000 |
8,494,151 |
18.8% |
-86,301,000 |
0 |
14.171 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
2 |
- |
$0.44 |
$142,483,000 |
6,893,235 |
6.28% |
2,939,000 |
855,000 |
4.803 |
Biotechnology |
|
|
ACLX |
Arcellx, Inc. |
3 |
- |
$0.00 |
$123,799,000 |
1,780,000 |
5.45% |
29,449,000 |
80,000 |
3.635 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
4 |
- |
$64.97 |
$107,028,000 |
2,700,000 |
4.72% |
58,425,000 |
150,000 |
4.12 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
5 |
- |
$29.28 |
$99,038,000 |
3,203,029 |
4.36% |
-35,967,000 |
-141,150 |
1.841 |
N/A |
|
|
PRAX |
Praxis Precision Medicines,... |
6 |
- |
$0.00 |
$79,936,000 |
1,310,000 |
3.52% |
65,825,000 |
676,655 |
2.5 |
N/A |
|
|
CRBP |
Corbus Pharmaceuticals Hold... |
7 |
New |
$45.20 |
$79,461,000 |
2,025,000 |
3.5% |
79,461,000 |
2,025,000 |
1.616 |
N/A |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
8 |
- |
$0.00 |
$77,756,000 |
2,139,102 |
3.43% |
32,772,000 |
-82,320 |
6.461 |
N/A |
|
|
LBPH |
Longboard Pharmaceuticals, ... |
9 |
- |
$0.00 |
$72,428,000 |
3,353,141 |
3.19% |
58,239,000 |
1,000,000 |
19.818 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
10 |
- |
$0.00 |
$54,839,000 |
3,006,534 |
2.42% |
26,920,000 |
454,545 |
3.258 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
11 |
- |
$49.50 |
$53,832,000 |
1,150,000 |
2.37% |
12,915,000 |
0 |
1.565 |
N/A |
|
|
BMEA |
Biomea Fusion, Inc. |
12 |
- |
$11.58 |
$53,385,000 |
3,570,872 |
2.35% |
1,536,000 |
0 |
12.412 |
N/A |
|
|
KRRO |
Korro Bio |
13 |
- |
$0.00 |
$47,625,000 |
529,170 |
2.1% |
22,262,000 |
0 |
1.573 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
14 |
- |
$0.00 |
$46,792,000 |
685,000 |
2.06% |
5,030,000 |
20,000 |
0.635 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
15 |
- |
$3.87 |
$42,214,000 |
6,616,667 |
1.86% |
7,116,000 |
1,166,667 |
3.823 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
16 |
- |
$0.00 |
$39,552,000 |
1,711,460 |
1.74% |
-8,454,000 |
0 |
4.133 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
17 |
New |
$0.00 |
$35,475,000 |
1,500,000 |
1.56% |
35,475,000 |
1,500,000 |
1.839 |
N/A |
|
|
CGON |
CG Oncology, Inc |
18 |
New |
$28.97 |
$35,120,000 |
800,000 |
1.55% |
35,120,000 |
800,000 |
1.212 |
N/A |
|
|
ALXO |
Alx Oncology Holdings Inc |
19 |
- |
$0.00 |
$35,034,000 |
3,142,079 |
1.54% |
-11,752,000 |
0 |
6.307 |
N/A |
|
|
BHVN |
Biohaven Ltd. |
20 |
- |
$38.72 |
$33,742,000 |
616,963 |
1.49% |
30,234,000 |
535,000 |
0.769 |
N/A |
|
|
MRUS |
Merus Nv |
21 |
New |
$43.72 |
$32,196,000 |
715,000 |
1.42% |
32,196,000 |
715,000 |
1.239 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
22 |
- |
$0.00 |
$31,634,000 |
1,069,796 |
1.39% |
4,213,000 |
-141,900 |
3.866 |
N/A |
|
|
ABVX |
Abivax S.A |
23 |
- |
$14.31 |
$30,459,000 |
2,130,000 |
1.34% |
7,668,000 |
0 |
3.435 |
N/A |
|
|
HLXB |
Helix Acquisition Corp. Ii |
24 |
New |
$10.25 |
$30,254,000 |
2,909,000 |
1.33% |
30,254,000 |
2,909,000 |
15.81 |
N/A |
|
|
MRNS |
Marinus Pharmaceuticals Inc |
25 |
- |
$1.33 |
$29,380,000 |
3,250,000 |
1.29% |
-5,948,000 |
0 |
5.838 |
N/A |
|
|
TRML |
Tourmaline Bio |
26 |
New |
$0.00 |
$28,625,000 |
1,250,000 |
1.26% |
28,625,000 |
1,250,000 |
3.026 |
N/A |
|
|
JANX |
Janux Therapeutics, Inc. |
27 |
New |
$0.00 |
$28,238,000 |
750,000 |
1.24% |
28,238,000 |
750,000 |
1.88 |
N/A |
|
|
NGNE |
Neurogene |
28 |
- |
$3.68 |
$27,421,000 |
538,714 |
1.21% |
12,960,000 |
-207,466 |
1.286 |
N/A |
|
|
CRGX |
Cargo Therapeutics, Inc. |
29 |
- |
$0.00 |
$26,395,000 |
1,182,563 |
1.16% |
-981,000 |
0 |
0 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
30 |
- |
$38.01 |
$23,832,000 |
550,000 |
1.05% |
-1,452,000 |
0 |
0.775 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
31 |
- |
$42.56 |
$23,512,000 |
400,000 |
1.04% |
-13,901,000 |
-225,000 |
0.349 |
N/A |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
32 |
New |
$9.48 |
$21,059,000 |
2,125,000 |
0.93% |
21,059,000 |
2,125,000 |
1.996 |
N/A |
|
|
IDYA |
Ideaya Biosciences, Inc. |
33 |
- |
$0.00 |
$19,746,000 |
450,000 |
0.87% |
3,735,000 |
0 |
0.624 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
34 |
- |
$0.00 |
$18,766,000 |
1,100,000 |
0.83% |
18,766,000 |
1,100,000 |
2.139 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
35 |
New |
$9.20 |
$18,298,000 |
1,300,000 |
0.81% |
18,298,000 |
1,300,000 |
2.378 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
36 |
New |
$13.27 |
$16,950,000 |
1,000,000 |
0.75% |
16,950,000 |
1,000,000 |
4.31 |
N/A |
|
|
INSM |
Insmed Inc |
37 |
- |
$24.53 |
$15,600,000 |
575,000 |
0.69% |
-2,219,000 |
0 |
0.379 |
Biotechnology |
|
|
VTYX |
Ventyx Biosciences, Inc. |
38 |
New |
$4.74 |
$14,905,000 |
2,710,000 |
0.66% |
14,905,000 |
2,710,000 |
5.388 |
N/A |
|
|
NKTX |
Nkarta, Inc. |
39 |
New |
$0.00 |
$14,594,000 |
1,350,000 |
0.64% |
14,594,000 |
1,350,000 |
2.774 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
40 |
New |
$0.00 |
$13,500,000 |
625,000 |
0.59% |
13,500,000 |
625,000 |
2.097 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
41 |
New |
$2.62 |
$11,648,000 |
2,600,000 |
0.51% |
11,648,000 |
2,600,000 |
2.156 |
N/A |
|
|
CMPX |
Compass Therapeutics Ord Shs |
42 |
New |
$0.00 |
$11,009,000 |
5,560,300 |
0.49% |
11,009,000 |
5,560,300 |
5.672 |
N/A |
|
|
KYTX |
Kyverna Therapeutics |
43 |
New |
$13.70 |
$10,930,000 |
440,000 |
0.48% |
10,930,000 |
440,000 |
1.023 |
N/A |
|
|
IMRX |
Immuneering Corp |
44 |
- |
$0.00 |
$9,523,000 |
3,295,273 |
0.42% |
-21,379,000 |
-909,091 |
12.703 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
45 |
- |
$0.60 |
$9,483,000 |
250,000 |
0.42% |
-10,683,000 |
-687,080 |
0.409 |
N/A |
|
|
AVBP |
Arrivent Biopharma, Inc. |
46 |
New |
$19.95 |
$9,198,000 |
515,000 |
0.41% |
9,198,000 |
515,000 |
1.538 |
N/A |
|
|
RCKT |
Rocket Pharmaceuticals |
47 |
- |
$22.33 |
$8,082,000 |
300,000 |
0.36% |
-5,405,000 |
-150,000 |
0.324 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
48 |
- |
$31.26 |
$7,783,000 |
125,000 |
0.34% |
563,000 |
0 |
0.518 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
49 |
- |
$0.00 |
$6,346,000 |
561,600 |
0.28% |
1,876,000 |
0 |
0.642 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
50 |
- |
$0.00 |
$6,322,000 |
593,043 |
0.28% |
2,882,000 |
0 |
1.214 |
N/A |
|
|
STOK |
Stoke Therapeutics, Inc. |
51 |
- |
$0.00 |
$5,767,000 |
427,163 |
0.25% |
45,000 |
-660,644 |
0.898 |
N/A |
|
|
LNTH |
Lantheus Holdings, Inc. |
52 |
- |
$80.70 |
$4,668,000 |
75,000 |
0.21% |
18,000 |
0 |
0.104 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
53 |
- |
$0.00 |
$4,648,000 |
350,000 |
0.2% |
-231,000 |
0 |
0.435 |
N/A |
|
|
RAPT |
Rapt Therapeutics, Inc. |
54 |
- |
$4.59 |
$4,461,000 |
496,750 |
0.2% |
-7,883,000 |
0 |
1.376 |
N/A |
|
|
VYNE |
VYNE Therapeutics Inc |
55 |
- |
$0.22 |
$4,281,000 |
1,394,336 |
0.19% |
1,032,000 |
0 |
2.716 |
N/A |
|
|
BCAB |
Bioatla, Inc. |
56 |
- |
$0.00 |
$4,028,000 |
1,170,870 |
0.18% |
1,122,000 |
-10,245 |
2.539 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
60 |
Closed |
$0.00 |
$0 |
0 |
0% |
-34,469,000 |
-2,456,800 |
0 |
N/A |
|
|
RYZB |
Rayzebio, Inc. |
57 |
Closed |
$62.49 |
$0 |
0 |
0% |
-75,442,000 |
-1,213,478 |
0 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
59 |
Closed |
$20.66 |
$0 |
0 |
0% |
-25,392,000 |
-1,175,000 |
0 |
N/A |
|
|
AXNX |
Axonics Modulation Technolo... |
65 |
Closed |
$67.59 |
$0 |
0 |
0% |
-15,558,000 |
-250,000 |
0 |
N/A |
|
|
HARP |
Harpoon Therapeutics, Inc. |
64 |
Closed |
$0.89 |
$0 |
0 |
0% |
-22,551,000 |
-2,349,060 |
0 |
N/A |
|
|
IMVT |
Immunovant Inc |
63 |
Closed |
$0.00 |
$0 |
0 |
0% |
-49,081,000 |
-1,165,000 |
0 |
N/A |
|
|
NMRA |
Neumora Therapeutics, Inc. |
62 |
Closed |
$9.45 |
$0 |
0 |
0% |
-1,574,000 |
-92,293 |
0 |
N/A |
|
|
AMAM |
Ambrx Biopharma Adr Represe... |
61 |
Closed |
$0.00 |
$0 |
0 |
0% |
-159,929,000 |
-11,231,000 |
0 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
58 |
Closed |
$32.48 |
$0 |
0 |
0% |
-42,516,000 |
-1,800,000 |
0 |
N/A |
|
